Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
DNA vaccination for prostate cancerAnna-Karin Roos, Alan King, Pavel Pisa
Immunology and Cell Biology|September 15, 2010
Plasmid DNA vaccination using skin electroporation promotes poly-functional CD4 T-cell responsesAndreas Bråve, Sanna Nyström, Anna-Karin Roos, et al.
The Prostate|September 25, 2004
Induction of PSA-specific CTLs and anti-tumor immunity by a genetic prostate cancer vaccineAnna-Karin Roos, Maxim Pavlenko, Jehad Charo, et al.
The Prostate|January 15, 2005
Identification of an immunodominant H-2D(b)-restricted CTL epitope of human PSAMaxim Pavlenko, Christoph Leder, Anna-Karin Roos, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 28, 2005
Enhancement of cellular immune response to a prostate cancer DNA vaccine by intradermal electroporationAnna-Karin Roos, Sonia Moreno, Christoph Leder, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 18, 2009
Optimization of skin electroporation in mice to increase tolerability of DNA vaccine delivery to patientsAnna-Karin Roos, Fredrik Eriksson, Derin C Walters, et al.
Cancer Immunology, Immunotherapy : CII|February 8, 2005
Comparison of PSA-specific CD8+ CTL responses and antitumor immunity generated by plasmid DNA vaccines encoding PSA-HSP chimeric proteinsMaxim Pavlenko, Anna-Karin Roos, Christoph Leder, et al.
Cancer Immunology, Immunotherapy : CII|June 16, 2009
Intradermal DNA electroporation induces survivin-specific CTLs, suppresses angiogenesis and confers protection against mouse melanomaAlvaro Lladser, Karl Ljungberg, Helena Tufvesson, et al.
Journal of Neurology|January 9, 2026
Heterogeneous phenotype and cardiovascular comorbidities in Swedish patients with spinobulbar muscular atrophyAnna-Karin Roos, Simon Forsberg, Erica Stenvall, et al.
Cancer Immunology, Immunotherapy : CII|September 30, 2008
HER-2/neu mediated down-regulation of MHC class I antigen processing prevents CTL-mediated tumor recognition upon DNA vaccination in HLA-A2 transgenic miceSimona Vertuani, Chiara Triulzi, Anna Karin Roos, et al.
Pageof 2